Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy

Endocrine

Volumn 44, Issue 1, 2013, Pages 140-144

  Cai, Kebo ^a   Wei, Ruili ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Graves' ophthalmopathy; Interleukin 7; Orbital tissues; Tears

Indexed keywords

INTERLEUKIN 7;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACRIMAL FLUID; LACRIMAL FLUID LEVEL; ORBIT; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-7; MALE; ORBIT; OSMOLAR CONCENTRATION; TEARS;

EID: 84881169262     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9840-7     Document Type: Article

References (44)

1. J.A. Garrity, R.S. Bahn, Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am. J. Ophthalmol. 142, 147-153 (2006)
2. L. Bartalena, A. Pinchera, C. Marcocci, Management of Graves' ophthalmopathy: reality and perspectives. Endocr. Rev. 21, 168-199 (2000)
3. M.V. Brasil, O.F. Brasil, R.P. Vieira et al., Tear film analysis and its relation with palpebral fissure height and exophthalmos in Graves' ophthalmopathy. Arq. Bras. Oftalmol. 68, 615-618 (2005)
4. G. Iskeleli, Y. Karakoc, A. Abdula, Tear film osmolarity in patients with thyroid ophthalmopathy. Jpn. J. Ophthalmol. 52, 323-326 (2008)
5. A.K. Khurana, S. Sunder, B.K. Ahluwalia, Tear film profile in Graves' ophthalmopathy. Acta Ophthalmol. (Copenh) 70, 346-349 (1992)
6. R.H. Chen, W.C. Chen, C.T. Chang et al., Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J. Clin. Lab. Anal. 19, 133-138 (2005)
7. S.L. Reiner, Development in motion: helper T cells at work. Cell 129, 33-36 (2007)
8. R. Hofmeister, A.R. Khaled, N. Benbernou et al., Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev. 10, 41-60 (1999)
9. A. Bikker, C.E. Hack, F.P. Lafeber et al., Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. Curr. Pharm. Des. 18, 2347-2356 (2012)
10. A. Link, T.K. Vogt, S. Favre et al., Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. 8, 1255-1265 (2007)
11. T. Junt, E. Scandella, B. Ludewig, Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat. Rev. Immunol. 8, 764-775 (2008)
12. R. Mazzucchelli, S.K. Durum, Interleukin-7 receptor expression: intelligent design. Nat. Rev. Immunol. 7, 144-154 (2007)
13. R. Rübenhagen, J.P. Schüttrumpf, K.M. Stürmer et al., Interleukin-7 levels in synovial fluid increase with age and MMP-1 levels decrease with progression of osteoarthritis. Acta Orthop. 83, 59-64 (2012)
14. A.M. Crawley, J.B. Angel, The influence of HIV on CD127 expression and its potential implications for IL-7 therapy. Semin. Immunol. 24, 231-240 (2012)
15. L. Vassena, H. Miao, R. Cimbro et al., Treatment with IL-7 prevents the decline of circulating CD4 + T cells during the acute phase of SIV infection in rhesus macaques. PLoS Pathog. 8, e1002636 (2012)
16. O. Yamaji, T. Nagaishi, T. Totsuka et al., The development of colitogenic CD4 (+) T cells is regulated by IL-7 in collaboration with NK cell function in a murine model of colitis. J. Immunol. 15, 2524-2536 (2012)
17. S. Koyasu, K. Moro, Role of innate lymphocytes in infection and inflammation. Front Immunol. 3, 101 (2012)
18. C. Penaranda, W. Kuswanto, J. Hofmann et al., IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proc. Natl. Acad. Sci. U S A 109, 12668-12673 (2012)
19. G.B. Bartley, C.A. Gorman, Diagnostic criteria for Graves' ophthalmopathy. Am. J. Ophthalmol. 119, 792-795 (1995)
20. D. Huang, N. Xu, Y. Song et al., Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy. Graefes Arch. Clin. Exp. Ophthalmol. 250, 619-625 (2012)
21. A.G. Gianoukakis, N. Khadavi, T.J. Smith, Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid 18, 953-958 (2008)
22. B. Ujhelyi, P. Gogolak, A. Erdei et al., Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines. Thyroid 22, 407-414 (2012)
23. L. van Steensel, H. Hooijkaas, D. Paridaens et al., PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients. J. Clin. Endocrinol. Metab. 97, E944-E953 (2012)
24. A.M. Avunduk, M.C. Avunduk, H. Pazarli et al., Immunohistochemical analysis of orbital connective tissue specimens of patients with active Graves ophthalmopathy. Curr. Eye Res. 30, 631-638 (2005)
25. J.R. Wall, M. Salvi, N.F. Bernard et al., Thyroid-associated ophthalmopathy-a model for the association of organ-specific autoimmune disorders. Immunol. Today 12, 150-153 (1991)
26. R.S. Bahn, Graves's ophthalmopathy. N. Engl. J. Med. 362, 726-738 (2010)
27. Y. Hiromatsu, H. Kaku, I. Miyake et al., Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 12, 217-221 (2002)
28. R. Moncayo, I. Baldissera, C. Decristoforo et al., Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin amalog111In-octreotide. Thyroid 7, 21-29 (1997)
29. A.K. Eckstein, M. Plicht, H. Lax et al., Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J. Clin. Endocrinol. Metab. 91, 3464-3470 (2006)
30. ' disease. Ophthalmology 88, 553-564 (1981)
31. H.A. Khalil, R.J. De Keizer, V.M. Bodelier et al., Secretory IgA and lysozyme in tears of patients with Graves' ophthalmopathy. Doc. Ophthalmol. 72, 329-334 (1989)
32. A. Gupta, P.B. Sadeghi, E.K. Akpek, Occult thyroid eye disease in patients presenting with dry eye symptoms. Am. J. Ophthalmol. 147, 919-923 (2009)
33. K.L. Komschlies, K.J. Grzegorzewski, R.H. Wiltrout, Diverse immunological and hematological effects of interleukin-7: implication for clinical application. J. Leukoc. Biol. 58, 623-633 (1995)
34. F. Simonetta, N. Gestermann, K.Z. Martinet et al., Interleukin-7 influences FOXP3+CD4+ regulatory T cells peripheral homeostasis. PLoS ONE 7, E36596 (2012)
35. M. Pellegrini, T. Calzascia, J.G. Toe et al., IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 144, 601-613 (2011)
36. A. Ryden, K. Stechova, M. Durilova et al., Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes. Diabetes Metab. Res. Rev. 25, 335-343 (2009)
37. S.R. Pickens, N.D. Chamberlain, M.V. Volin et al., Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 63, 2884-2893 (2011)
38. R. Liaria, B. Giacomina, G. Eva et al., IL-7 up-regulates TNF-α-dependent osteoclastogenesis in patients affected by solid tumor. PLoS ONE 1, 1-9 (2006)
39. M. Pellegrini, TW. Tumor immune therapy: lessons from infection and implications for cancer can IL-7 help overcome immune inhibitory networks? Eur. J. Immunol. 40, 1852-1861 (2010)
40. M. Huang, S. Sharma, L.X. Zhu et al., IL7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis. J. Clin. Invest. 109, 931-937 (2002)
41. L. Zhang, M.P. Keane, L.X. Zhu et al., Interleukin-7 and transforming growth factor-β play counter-regulatory roles in protein kinase C-dependent control of fibroblast collagen synthesis in pulmonary fibrosis. J. Biol. Chem. 279, 28315-28319 (2004)
42. L. Koumas, T.J. Smith, S. Feldon et al., Thy-1 expression in human fibroblast subsets defines myo-fibroblastic or lipofibroblastic phenotypes. Am. J. Pathol. 163, 1291-1300 (2003)
43. A. Grigorian, H. Mkhikian, M. Demetriou, Interleukin-2, interleukin-7, T cell-mediated autoimmunity, and N-glycosylation. Ann. N. Y. Acad. Sci. 1253, 49-57 (2012)
44. C.M. Henriques, J. Rino, R.J. Nibbs et al., IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells. Blood 115, 3269-3277 (2010)